Published in:
01-09-2012
ACTH-Secreting Pheochromocytoma with False-Negative ACTH Immunohistochemistry
Authors:
Maria Francesca Cassarino, Alberto Giacinto Ambrogio, Luca Pagliardini, Martina De Martin, Valeria Barresi, Francesco Cavagnini, Francesca Pecori Giraldi
Published in:
Endocrine Pathology
|
Issue 3/2012
Login to get access
Excerpt
Since 1955, when Roux [
1] published the first association between pheochromocytoma and Cushing’s syndrome, we have come to appreciate the unique features of this unusual clinical entity. Pheochromocytoma represents a rare cause of hypercortisolism, accounting for less than 5 % of ectopic Cushing’s syndrome [
2,
3] while less than 1 % of pheochromocytomas is accompanied by Cushing’s syndrome [
4]. Pheochromocytomas are known to be heterogeneous, both functionally and clinically, a likely consequence of their ability to synthesize and secrete peptides in addition to catecholamine, such as vasoactive intestinal polypeptide, somatostatin, and calcitonin [
5]. As regards hypothalamo–pituitary–adrenal axis peptides, both adrenocorticotropin (ACTH) and other proopiomelanocortin (POMC)-derived peptides [
6,
7] as well as, occasionally, corticotropin-releasing hormone (CRH) [
8] have been demonstrated in pheochromocytomas associated with ectopic Cushing’s syndrome. …